Rule 8.3 - INVERNESS MEDICAL INNOVATIONS INC

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing BARCLAYS PLC (Note 1) Company dealt in INVERNESS MEDICAL INNOVATIONS INC Class of relevant security COM STK USD0.001 to which the dealings being disclosed relate (Note 2) Date of dealing 19 June 2009 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant 2,131,548 2.71% 71,968 0.09% securities (2) Derivatives 0 0.00% 0 0.00% (other than options) (3) Options and 144,600 0.18% 64,600 0.08% agreements to purchase/sell Total 2,276,148 2.89% 136,568 0.17% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of Long Short relevant security: Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of Securities Price per unit (GBP) Purchase 24,523 34.3900 USD Purchase 3,675 34.3900 USD Purchase 716 34.3900 USD Purchase 327 34.3900 USD Sale 24,630 34.3900 USD Sale 3,675 34.3900 USD Sale 1,183 34.8551 USD Sale 800 34.8725 USD Sale 234 34.9185 USD Sale 51 34.3900 USD Sale 51 34.3900 USD (b) Derivatives transactions (other than options) Product name, Long/Short Number of Price per (e.g. CFD) (Note 6) Securities unit (GBP) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, Number of Exercise Type, e.g. Expiry Option money e.g. call selling, securities to price American, date paid/received option purchasing, which the option European etc. per unit (GBP) varying etc. relates (GBP) Call Purchase 100 30 American 20/06/2009 4.2 Call Purchase 100 35 American 22/08/2009 2.100 Call Purchase 100 35 American 21/11/2009 4.000 Call Purchase 100 40 American 22/08/2009 0.600 Call Purchase 200 30 American 20/06/2009 4.2 Call Purchase 200 35 American 21/11/2009 3.650 Call Purchase 300 30 American 20/06/2009 4.496 Call Purchase 300 40 American 22/08/2009 0.600 Call Purchase 400 35 American 18/07/2009 1.125 Call Purchase 600 35 American 18/07/2009 1.400 Call Purchase 800 35 American 20/06/2009 0.125 Call Purchase 800 35 American 21/11/2009 4.000 Call Purchase 900 30 American 20/06/2009 4.678 Call Purchase 1000 35 American 18/07/2009 1.200 Call Purchase 3500 35 American 20/06/2009 0.026 Call Sale 100 30 American 20/06/2009 4.2 Call Sale 100 35 American 20/06/2009 0.100 Call Sale 100 35 American 22/08/2009 2.100 Call Sale 100 35 American 22/08/2009 2.300 Call Sale 100 40 American 22/08/2009 0.600 Call Sale 200 35 American 21/11/2009 3.650 Call Sale 300 30 American 20/06/2009 4.496 Call Sale 300 40 American 22/08/2009 0.600 Call Sale 400 35 American 18/07/2009 1.125 Call Sale 400 35 American 22/08/2009 2.300 Call Sale 600 35 American 18/07/2009 1.490 Call Sale 800 35 American 20/06/2009 0.125 Call Sale 900 30 American 20/06/2009 4.678 Call Sale 3500 35 American 20/06/2009 0.026 Put Purchase 100 30 American 22/08/2009 1.050 Put Purchase 100 35 American 20/06/2009 0.282 Put Purchase 100 35 American 20/06/2009 0.350 Put Purchase 100 35 American 20/06/2009 0.383 Put Purchase 100 35 American 18/07/2009 1.600 Put Purchase 100 35 American 18/07/2009 1.750 Put Purchase 400 30 American 22/08/2009 1.050 Put Purchase 400 35 American 18/07/2009 1.900 Put Purchase 5000 30 American 22/08/2009 1.000 Put Sale 100 30 American 22/08/2009 1.000 Put Sale 100 30 American 22/08/2009 1.050 Put Sale 100 35 American 20/06/2009 0.282 Put Sale 100 35 American 20/06/2009 0.383 Put Sale 400 30 American 22/08/2009 1.050 Put Sale 400 35 American 18/07/2009 1.900 (ii) Exercising Product name, e.g. Number of Exercise price per call option securities unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION None Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 22 June 2009 Contact name Geoff Smith Telephone number 020 7116 2913 If a connected EFM, name of offeree/offeror with which connected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

Companies

Barclays (BARC)
UK 100

Latest directors dealings